# motionhall.com > AI-optimized mirror of motionhall.com containing 24 pages totalling 16,089 words of clean markdown content, structured data, and semantic HTML. Original source: https://motionhall.com/. Last updated: 2026-06-15T05:51:51.753Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [Your Business](/content/site-root.html): MotionHall helps pharma and biotech companies close more valuable licensing and M&A deals by putting a powerful professional suite of modern technology and services at the fingertips of business development professionals. (464 words) ## Articles & Blog Posts - [Informing Investor Valuations](/content/casestudy/investor-financing/index.html): As a Platform member, get access to the whole picture — the picture investors need to value your company correctly. (784 words) - [Building Your Platform Technology Strategy](/content/casestudy/building-platform-tech-strategy/index.html): Most biotech licensing and partnering deals focus on a single asset, in only one specific indication. How should the leadership team of a platform company approach deal-making? (1,196 words) - [Tailored, empathic outreach is key to connecting with busy executives.](/content/casestudy/beginning-new-relationships/index.html): Tailored, empathic outreach is key to connecting with busy executives. (910 words) - [The Platform is Best Leveraged by a Sophisticated BD Team](/content/casestudy/building-internal-bd-muscle/index.html): Biopharmaceutical business development teams often need to ramp-up quickly and learn new skills at the firehose. Meanwhile, strategic transactions are time sensitive and have a serious cost on opportunity when mishandled. (857 words) - [The CEO-Led Journey](/content/casestudy/the-ceo-led-journey/index.html): Nobody cares as much about the future of a company as the people on the ground. (1,131 words) - [Scenario One: Oakbough Partners Runs a Best-in-Class Traditional Process for a Phase 3 Transaction](/content/casestudy/a-tale-of-two-deals/index.html): Working with a smaller market with few well-suited potential transaction partners can be challenging, but at MotionHall, we believe that if the product stands up to diligence, you can always win. The key is to know the market for your deal and plan your process well. (1,115 words) - [A seasoned CBO knows never letting up on stoking competitive pressure is key to ensuring transacting on time and at the best value](/content/casestudy/protecting-downside/index.html): A seasoned CBO knows never letting up on stoking competitive pressure is key to ensuring transacting on time and at the best value (830 words) - [Strategy Consulting and Services for Accelerated Outreach and Introductions](/content/casestudy/accelerated-outreach/index.html): MotionHall offers tailored services to achieve your outreach goals faster. (737 words) - [Privacy Policy](/content/privacy-policy/index.html): Read MotionHall's Privacy Policy. MotionHall helps pharma and biotech companies close more valuable licensing and M&A deals by putting a powerful professional suite of modern technology and services at the fingertips of business development professionals. (1,434 words) - [Novel Science Requires Mastering the Scientific Sale](/content/casestudy/novel-science/index.html): The key with novelty is to master the scientific sale. That means you will focus on mastering conversations with the scientific experts who can help champion your case inside companies. (922 words) - [Empowering dealmakers,](/content/team/index.html): Leveraged on top of technology, teammates at MotionHall work to maintain a team as small and high-powered as possible so that we can assure quality and agility in results for our membership. (582 words) - [Achieving Licensing Success in a Niche Market](/content/casestudy/niche-markets/index.html): When working with niche markets, every detail counts. (833 words) - [The CEO-Led Journey](/content/casestudies/index.html): MotionHall's case studies provide valuable insights for BD professionals approaching out-licensing and in-licensing deals. (420 words) - [Plainly Stated](/content/plainly-stated/index.html): Read MotionHall's Plainly Stated. MotionHall helps pharma and biotech companies close more valuable licensing and M&A deals by putting a powerful professional suite of modern technology and services at the fingertips of business development professionals. (361 words) - [A place for impact-oriented, intellectual horsepower.](/content/careers/index.html): We built MotionHall to be a place where brilliant people can be challenged to become the greatest version of themselves, and make a meaningful impact in healthcare progress at the same time. (424 words) - [EU Privacy & Data Collection](/content/eu-privacy/index.html): Read MotionHall's Privacy Policy. MotionHall helps pharma and biotech companies close more valuable licensing and M&A deals by putting a powerful professional suite of modern technology and services at the fingertips of business development professionals. (377 words) - [Tell us about yourself.](/content/contact/index.html): Help our Strategy Consulting team be best prepared to speak to you. (195 words) - [What is a Deal Worth?](/content/whitepaper/partnering-in-europe/index.html): When considering the costs for a European partnership there are the short-term costs related to the transaction process and the longer-term costs related to losing control of your product in the licensed territory. (370 words) - [Anatomy of an Outlicensing Deal](/content/whitepaper/anatomy-of-a-deal/index.html): For individuals that are either new to the pharmaceutical industry or the disciplines of biopharma dealmaking, the process of how a licensing deal emerges and subsequently gets signed might not be that obvious. (359 words) - [What is a Deal Worth?](/content/whitepaper/partnering-in-china/index.html): The Chinese pharmaceutical industry is growing, both in terms of the size of the market for Western-style medicines versus traditional Chinese medicines and the number of companies now active in developing Western-style medicines. (327 words) - [Your Business Development Strategy](/content/whitepaper/your-bd-strategy/index.html): If you are an emerging biotech company focusing on out-licensing, the following seven steps are designed to empower dealmakers with proven, actionable guidelines, to creating a business development strategy. (293 words) - [A Business Development Powerhouse](/content/about/index.html): MotionHall is a Silicon Valley technology company first and this sets us apart. With MotionHall, you can access tools unlike any database provider, and strategic consulting support unlike any boutique bank or firm. (723 words) - [Your Business Development Strategy](/content/whitepapers/index.html): MotionHall's white papers provide valuable insights for approaching the global partnering landscape (445 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/robots.txt): Crawler directives